| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2005 | CA2159480C (s)-alpha-phenyl-2-pyridineethanamine benzoate and its use as a medicament |
| 01/25/2005 | CA2159478C (s)-alpha-phenyl-2-pyridineethanamine (s)-malate and its use as a medicament |
| 01/25/2005 | CA2131683C Stilbene derivatives and pharmaceutical compositions containing them |
| 01/25/2005 | CA2129455C Orally active azole derivatives |
| 01/25/2005 | CA2103383C Quinazoline derivatives |
| 01/25/2005 | CA2068224C Novel potent inducers of terminal differentiation and method of use thereof |
| 01/21/2005 | CA2435196A1 Radical and etiological method of treatment for premature wrinkles and aging |
| 01/20/2005 | WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 01/20/2005 | WO2005006806A1 Wireless microphone communication system |
| 01/20/2005 | WO2005005632A2 SMALL INTERFERING RNA SPECIFIC TO SUB-UNITS $G(A), $G(A)' AND $G(B) OF THE KINASE PROTEIN CK2, AND THE APPLICATIONS OF THE SAME |
| 01/20/2005 | WO2005005606A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2005005456A2 Peptide deformylase inhibitors |
| 01/20/2005 | WO2005005447A2 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 01/20/2005 | WO2005005439A1 Benzothiazino indoles |
| 01/20/2005 | WO2005005438A1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting prot ein kinases |
| 01/20/2005 | WO2005005434A1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 01/20/2005 | WO2005005433A1 Therapeutic agent for hyperpotassemia and bone disease |
| 01/20/2005 | WO2005005431A2 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 01/20/2005 | WO2005005427A1 PYRROLO[3,4-c]PYRAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS |
| 01/20/2005 | WO2005005425A1 N-(heterobicycloalkanes)-subtituted indoles- or heteroderivatives thereof |
| 01/20/2005 | WO2005005418A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 01/20/2005 | WO2005005417A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | WO2005005416A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 01/20/2005 | WO2005005414A2 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 01/20/2005 | WO2005005398A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005005395A2 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | WO2005005393A2 Cck-1 receptor modulators |
| 01/20/2005 | WO2005005390A1 Novel enzyme inhibitor |
| 01/20/2005 | WO2005005383A1 Amino alcohol compound |
| 01/20/2005 | WO2005005380A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | WO2005005377A1 (2r, 5r)-6n-(1-iminoethyl)-2,6-diamino-5-methyl-4-thiohexanoic acid; salts thereof; a process for their preparation; pharmaceutical compositions containing them and their use in medecine |
| 01/20/2005 | WO2005005372A1 Compound having anti-hcv activity and process for producing the same |
| 01/20/2005 | WO2005005367A1 Chemically synthesized and highly unsaturated fatty acid of conjugated type |
| 01/20/2005 | WO2005004990A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | WO2005004988A2 Compositions and methods relating to novel compounds and targets thereof |
| 01/20/2005 | WO2005004926A1 Dendritic cell infiltrativity activating composition and immune activator |
| 01/20/2005 | WO2005004923A1 Tablet and process for producing the same |
| 01/20/2005 | WO2005004920A1 Stable non-dihydrate azithromycin oral suspensions |
| 01/20/2005 | WO2005004919A2 Extended release systems for macrolide antibiotics |
| 01/20/2005 | WO2005004915A2 Compositions comprising meloxicam |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004892A1 Plant worms mycelium extracat fraction and composition for oral intake |
| 01/20/2005 | WO2005004891A2 Use of an antioxidant in a dermatological and/or cosmetic composition |
| 01/20/2005 | WO2005004890A1 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 01/20/2005 | WO2005004889A1 Herbal compositions for the treatment and prevention of prostate disorders |
| 01/20/2005 | WO2005004882A1 Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof |
| 01/20/2005 | WO2005004881A1 Use of ribofuranose derivatives against inflammatory bowel diseases |
| 01/20/2005 | WO2005004880A1 Vaginal compositions for treating pelvic tissue infections and traumas |
| 01/20/2005 | WO2005004879A1 Intravascular delivery of non-viral nucleic acid |
| 01/20/2005 | WO2005004878A2 Multi-use vessels for vitamin d formulations, preferably administeredat high dose and periodically |
| 01/20/2005 | WO2005004877A1 Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| 01/20/2005 | WO2005004876A1 Method of preparing an aqueous meloxicam solution and aqueous solution thus produced |
| 01/20/2005 | WO2005004875A1 Medicinal composition for pulmonary administration |
| 01/20/2005 | WO2005004874A1 Stable tetrodotoxin freeze drying medicinal preparation |
| 01/20/2005 | WO2005004873A1 Use of antivirals against inflammatory bowel diseases |
| 01/20/2005 | WO2005004872A1 Cancer combination therapy comprising azd2171 and zd1839 |
| 01/20/2005 | WO2005004871A1 Combination therapy |
| 01/20/2005 | WO2005004870A1 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 01/20/2005 | WO2005004869A1 Use of cgrp antagonists in treatment and prevention of hot flushes in prostate cancer patients |
| 01/20/2005 | WO2005004868A1 Anti-coronavirus drug |
| 01/20/2005 | WO2005004867A2 Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor |
| 01/20/2005 | WO2005004866A1 Therapeutic agents useful for treating pain |
| 01/20/2005 | WO2005004865A1 Use of 5-ht4(a)-serotonin receptor agonists |
| 01/20/2005 | WO2005004862A2 Method for photodynamic inactivation of pathogens using ala |
| 01/20/2005 | WO2005004861A1 A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 01/20/2005 | WO2005004860A2 Novel solid pharmaceutical composition comprising amisulpride |
| 01/20/2005 | WO2005004859A1 Coumarin derivatives for the treatment of ophthalmic disorders |
| 01/20/2005 | WO2005004858A1 Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them |
| 01/20/2005 | WO2005004857A1 Method for treating acute pancreatitis |
| 01/20/2005 | WO2005004856A1 Antifungal composition |
| 01/20/2005 | WO2005004855A1 Treatment of premature ejaculation |
| 01/20/2005 | WO2005004854A2 Use of betaine for treating arteritis |
| 01/20/2005 | WO2005004853A1 Dry powder for inhalation comprising a formoterol salt and ciclesonide |
| 01/20/2005 | WO2005004851A1 Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate |
| 01/20/2005 | WO2005004850A1 Controlled release compositions of betahistine |
| 01/20/2005 | WO2005004849A2 Pharmaceutical formulation comprising levothyroxine sodium |
| 01/20/2005 | WO2005004848A1 The solid dispersion of tacrolimus |
| 01/20/2005 | WO2005004846A1 Pharmaceutical formulations |
| 01/20/2005 | WO2005004844A1 Hfc solution formulations containing an anticholinergic |
| 01/20/2005 | WO2005004836A2 Saquinavir mesylate oral dosage form |
| 01/20/2005 | WO2005004829A1 Powdery compositions and skin preparation containing the same for external use |
| 01/20/2005 | WO2005004817A2 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 01/20/2005 | WO2005004808A2 TETRACYCLIC COMPOUNDS AS c-MET INHIBITORS |
| 01/20/2005 | WO2005004806A2 Combination therapy for treating chronic inflammatory diseases |
| 01/20/2005 | WO2005004803A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004802A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/20/2005 | WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 01/20/2005 | WO2005004799A2 β-LACTAMASE INHIBITORS AND METHODS OF USE THEREOF |
| 01/20/2005 | WO2005004798A2 Methods for treating lentivirus infections |
| 01/20/2005 | WO2005004796A2 Sulfonylamino phenylacetamide derivatives and methods of their use |
| 01/20/2005 | WO2005004630A1 Composition with antioxidant activity for pharmaceutical or dietary or cosmetic use |
| 01/20/2005 | WO2004106519A3 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids |
| 01/20/2005 | WO2004105759A3 Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases |
| 01/20/2005 | WO2004101826A3 Methods to identify compounds that modulate the autoinducer-2 dependent quorum sensing system in vibrio harveyi |
| 01/20/2005 | WO2004100992A3 Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines |
| 01/20/2005 | WO2004100968A3 A synergistic composition for the treatment of diabetes mellitus |
| 01/20/2005 | WO2004100865A3 New benzimidazole derivatives |
| 01/20/2005 | WO2004098641A3 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |